Pharmacokinetic study of the new cyclosporine-a formulation (neoral™) in adult ALLO-BMT recipients

Gianpietro Dotti; Eleonora Gaspari; Raffaele Caruso; Norberto Perico; Giuseppe Remuzzi; Tiziano Barbui; Alessandro Rambaldi

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2001

Pharmacokinetic study of the new cyclosporine-A formulation (Neoral) in adult allogeneic bone marrow transplant recipients.

Gianpietro Dotti, Flavio Gaspari, Raffaele Caruso, Norberto Perico, Giuseppe Remuzzi, Tiziano Barbui, Alessandro Rambaldi

Article2006

Mycophenolic Acid Formulation Affects Cyclosporine Pharmacokinetics in Stable Kidney Transplant Recipients

Dario Cattaneo, Simona Merlini, Sara Baldelli, Barbara Bartolini, Annalisa Nicastri Biotechnologist, Eliana Gotti, Giuseppe Remuzzi, Norberto Perico

Article2001

Optimization of cyclosporine therapy in the neoral era: abbreviated AUC, single blood sampling?

Flavio Gaspari, R. Caruso, Dario Cattaneo, Norberto Perico, Giuseppe Remuzzi

Article2024

Safety and pharmacokinetic properties of a new formulation of parenteral artesunate in healthy Thai volunteers

Joel Tärning, Borimas Hanboonkunupakarn, Richard M. Hoglund, Kesinee Chotivanich, Mavuto Mukaka, Sasithon Pukrittayakamee, Nicholas Day, Sir Nicholas White, Arjen M. Dondorp, Podjanee Jittamala

Malaria Journal

Article2016

Conversion from Brand-Name Neoral to the Generic Ciqorin in Stable Renal Transplant Recipients

Monica Cortinovis, Eliana Gotti, Matias Trillini, Fabiola Carrara, Flavio Gaspari, Piero Ruggenenti, Giuseppe Remuzzi, Norberto Perico